Health Condition 1: null- locally advanced head & neck carcinomas
Conditions
Interventions
Control Intervention1: two doses of cisplatin: observing patients receiving two doses of cisplatin with concurent radiation in locally advanced squamous cell carcinomas of head &neck
Control Intervent
Sponsors
dept of Radiotherapy Oncology
Eligibility
Inclusion criteria
Inclusion criteria: patients with biopsy proven squamous cell carcinomas of head & neck with stages 3 & 4 patients with ECOG perfomance status 0 to 2 absolute granulocyte count more than 3ooo/mm3 platelet count more than 100000/mm3 normal renal & liver function tests
Exclusion criteria
Exclusion criteria: patients with metastatic disease on diagnostic imaging patients with previous history of radiotherapy & treatment for head & neck carcinoma & history of chemotherapy patients with treatment for any other malignancy associated serius medical illness like xeroderma pigmentosum, renal failure, cardiac failure, hepatic failure nasopharyngeal carcinomas, thyroid carcinomas, salivary gland carcinomas
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| acute toxicities & loco regional responseTimepoint: acute toxicities & loco regional response at 6 months of starting treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| feasibility of treatment deliveryTimepoint: feasibity of treatment delivery during the treatment. no specific time period for that. | — |
Countries
India
Contacts
Public ContactDr PL Rema
kerala university of health science
Outcome results
None listed